SYNTHETIC BIOLOGICS INC (SYN)
Institutional ownership reported to the SEC as of Q1 2025, across 17 quarters.
1
Reporting holders
$4
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Pandora Wealth, Inc. | $4 | 4 | 0.00% | new | FIRST |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2025 | 1 | $4 | 4 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $13.0K | 3,825 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 23 | $2.5M | 11,776,889 | 2 | 7 | 6 | 0.0% |
| Q1 2022 | 26 | $3.2M | 11,116,369 | 7 | 8 | 6 | 0.0% |
| Q4 2021 | 27 | $3.2M | 11,896,975 | 5 | 9 | 3 | 0.0% |
| Q3 2021 | 28 | $3.3M | 7,231,557 | 6 | 8 | 2 | 0.0% |
| Q2 2021 | 24 | $3.9M | 6,502,233 | 7 | 3 | 9 | 0.0% |
| Q1 2021 | 23 | $5.8M | 8,515,105 | 14 | 8 | 0 | 0.0% |
| Q4 2020 | 13 | $711.0K | 1,859,055 | 3 | 3 | 3 | 0.0% |
| Q3 2020 | 12 | $760.0K | 1,371,546 | 1 | 3 | 2 | 14.1% |
| Q2 2020 | 16 | $3.4M | 1,380,528 | 5 | 3 | 1 | 79.1% |
| Q1 2020 | 15 | $2.1M | 1,378,349 | 4 | 2 | 4 | 79.1% |
| Q4 2019 | 13 | $3.5M | 1,657,763 | 1 | 4 | 2 | 76.0% |
| Q3 2019 | 18 | $3.2M | 1,847,000 | 4 | 3 | 4 | 73.9% |
| Q2 2019 | 15 | $3.8M | 1,713,333 | 1 | 3 | 2 | 75.3% |
| Q1 2019 | 21 | $4.8M | 1,913,670 | 4 | 6 | 3 | 73.2% |
| Q4 2018 | 21 | $4.5M | 2,890,961 | 2 | 0 | 1 | 64.4% |